CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation - Sorbonne Université Accéder directement au contenu
Communication Dans Un Congrès Année : 2017

CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation

Domaines

Sciences du Vivant [q-bio]

Maryse Guerin  : Connectez-vous pour contacter le contributeur

https://hal.sorbonne-universite.fr/hal-03969914

Soumis le : jeudi 2 février 2023-15:11:45

Dernière modification le : lundi 22 avril 2024-10:48:20

Fichier non déposé

Dates et versions

hal-03969914 , version 1 (02-02-2023)

Identifiants

  • HAL Id : hal-03969914 , version 1

Citer

Jerome Caron, Veronique Pene, Maxime Villaret, Alexis Moravic, Eleanor Luce, et al.. CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation. 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Oct 2017, Washington, United States. ⟨hal-03969914⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS ICAN USPC SORBONNE-UNIVERSITE SU-MEDECINE UP-SANTE IHU_ICAN
38 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More